Iambic TherapeuticsPrice range
Iambic Therapeutics sets an IPO price range
Iambic Therapeutics sets an IPO price range (October 8, 2026).
Iambic Therapeutics develops a unified platform for drug discovery and development, covering hit identification, lead optimization and clinical developability.
Offering details
- Price range
- $15.0 to $17.0
- Shares offered
- 9.4M
- Exchange
- Nasdaq Global Select Market
- Proposed ticker
- IAM
IPO timeline
files for an IPO
Iambic Therapeutics
sets an IPO price range
Iambic Therapeutics